Mustang Bio, Inc. SEC filings MBIO
Mustang Bio, Inc. has 405 filings in SEC EDGAR's recent list, going back to Jul 28, 2016. Its latest annual report, Form 10-K, was filed on Mar 19, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 15, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Apr 11, 2025 | — |
| POS EX | Filing | Apr 1, 2025 | — |
| EFFECT | Filing | Feb 5, 2025 | — |
| CORRESP | Letter to the SEC | Feb 5, 2025 | — |
| UPLOAD | Letter from the SEC | Jan 20, 2025 | — |
| EFFECT | Filing | Nov 27, 2024 | — |
| CORRESP | Letter to the SEC | Nov 25, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 25, 2024 | — |
| EFFECT | Filing | Jul 29, 2024 | — |
| CORRESP | Letter to the SEC | Jul 25, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 25, 2024 | — |
| D | Filing | Jun 24, 2024 | — |
| EFFECT | Filing | Jun 12, 2024 | — |
| CORRESP | Letter to the SEC | Jun 10, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 4, 2024 | — |
| EFFECT | Filing | Apr 29, 2024 | — |
| EFFECT | Filing | Apr 29, 2024 | — |
| CORRESP | Letter to the SEC | Apr 29, 2024 | — |
| CORRESP | Letter to the SEC | Apr 29, 2024 | — |
| CORRESP | Letter to the SEC | Apr 29, 2024 | — |
| UPLOAD | Letter from the SEC | Mar 20, 2024 | — |
| UPLOAD | Letter from the SEC | Dec 18, 2023 | — |
| D | Filing | Nov 3, 2023 | — |
| UPLOAD | Letter from the SEC | Sep 6, 2023 | — |
| CORRESP | Letter to the SEC | Aug 28, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 23, 2023 | — |
| PX14A6G | Filing | Jun 15, 2021 | — |
| EFFECT | Filing | May 24, 2021 | — |
| CORRESP | Letter to the SEC | May 20, 2021 | — |
| UPLOAD | Letter from the SEC | Apr 28, 2021 | — |
| EFFECT | Filing | Dec 4, 2020 | — |
| CORRESP | Letter to the SEC | Dec 2, 2020 | — |
| UPLOAD | Letter from the SEC | Nov 2, 2020 | — |
| PX14A6G | Filing | May 29, 2020 | — |
| EFFECT | Filing | Sep 30, 2019 | — |
| CORRESP | Letter to the SEC | Sep 26, 2019 | — |
| UPLOAD | Letter from the SEC | Sep 10, 2019 | — |
| CORRESP | Letter to the SEC | Aug 30, 2019 | — |
| PRER14C | Filing | Aug 30, 2019 | — |
| UPLOAD | Letter from the SEC | Aug 22, 2019 | — |
| UPLOAD | Letter from the SEC | Aug 22, 2019 | — |
| EFFECT | Filing | Jul 27, 2018 | — |
| CORRESP | Letter to the SEC | Jul 24, 2018 | — |
| CORRESP | Letter to the SEC | Jul 20, 2018 | — |
| UPLOAD | Letter from the SEC | Jul 19, 2018 | — |
| CT ORDER | Filing | Nov 20, 2017 | — |
| CT ORDER | Filing | Sep 27, 2017 | — |
| CERTNAS | Auto-generated paper document | Aug 21, 2017 | — |
| 8-A12B | Filing | Aug 21, 2017 | — |
| D | Filing | Apr 12, 2017 | — |
| D/A | Filing | Feb 15, 2017 | — |
| D/A | Filing | Jan 13, 2017 | — |
| D/A | Filing | Jan 13, 2017 | — |
| D/A | Filing | Dec 13, 2016 | — |
| D/A | Filing | Nov 4, 2016 | — |
| UPLOAD | Letter from the SEC | Oct 24, 2016 | — |
| CT ORDER | Filing | Oct 24, 2016 | — |
| CORRESP | Letter to the SEC | Oct 18, 2016 | — |
| 10-12G/A | Filing | Oct 18, 2016 | — |
| D | Filing | Oct 17, 2016 | — |
| UPLOAD | Letter from the SEC | Oct 14, 2016 | — |
| CORRESP | Letter to the SEC | Oct 7, 2016 | — |
| 10-12G/A | Filing | Oct 7, 2016 | — |
| UPLOAD | Letter from the SEC | Sep 23, 2016 | — |
| CORRESP | Letter to the SEC | Sep 15, 2016 | — |
| 10-12G/A | Filing | Sep 15, 2016 | — |
| UPLOAD | Letter from the SEC | Aug 26, 2016 | — |
| 10-12G | Filing | Jul 28, 2016 | — |
Showing 68 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MBIO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Waltham, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1680048
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.